Maxeon Solar Technologies, Ltd. (MAXN)
NASDAQ: MAXN · Real-Time Price · USD
4.180
+0.310 (8.01%)
At close: Aug 1, 2025, 4:00 PM
4.260
+0.080 (1.91%)
After-hours: Aug 1, 2025, 7:50 PM EDT

Verve Therapeutics Revenue

In the year 2024, Maxeon Solar Technologies had annual revenue of $509.05M, down -54.68%. Maxeon Solar Technologies had revenue of $48.81M in the quarter ending December 31, 2024, a decrease of -78.66%.

Revenue (ttm)
$509.05M
Revenue Growth
-54.68%
P/S Ratio
0.05
Revenue / Employee
$319,955
Employees
1,591
Market Cap
70.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024509.05M-614.06M-54.68%
Dec 31, 20231.12B63.00M5.94%
Jan 1, 20231.06B276.83M35.34%
Jan 2, 2022783.28M-61.56M-7.29%
Jan 3, 2021844.84M-353.47M-29.50%
Dec 29, 2019 Pro Pro Pro
Dec 30, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apple400.37B
Microsoft281.72B
NVIDIA148.52B
Taiwan Semiconductor Manufacturing Company116.30B
Oracle57.40B
Broadcom57.05B
Cisco Systems55.62B
SAP SE42.15B
Revenue Rankings